Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Depreciation & Amortization (CF) (2011 - 2025)

Siga Technologies' (SIGA) quarterly Depreciation & Amortization (CF) came in at $116089.0 in Q3 2025, up 7.8% on a YoY basis from $107692.0 in Q3 2024, and down 29.51% quarter-over-quarter from $164692.0 in Q2 2025.

Analysis

Siga Technologies (SIGA) Depreciation & Amortization (CF) (2011 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Depreciation & Amortization (CF) for 15 consecutive years, with $116089.0 the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization (CF) rose 7.8% year-over-year to $116089.0; the trailing twelve-month figure through Dec 2025 stood at $416089.0 (down 22.72% YoY), and the FY2024 full-year result was $538421.0, changed 0.02% from the prior year.
  • Depreciation & Amortization (CF) eased to $116089.0 in Q3 2025 per SIGA's latest filing, from $164692.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $172474.0 in Q2 2022 and bottomed at $100000.0 in Q3 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $133306.0 across 5 years, with a median of $130826.0 in 2021.
  • The sharpest annual moves came in 2021 and 2023: Depreciation & Amortization (CF) fell 5.74% in 2021, then rose 16.96% in 2023.
  • Over 5 years, Depreciation & Amortization (CF) stood at $122368.0 in 2021, then dropped by 3.86% to $117643.0 in 2022, then grew by 16.96% to $137591.0 in 2023, then dropped by 4.99% to $130729.0 in 2024, then declined by 11.2% to $116089.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $116089.0, $164692.0, and $135308.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 1.96 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn -
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 1.62 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 3.97 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 26.48 Mn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn 24.20 Mn
10 Siga Technologies 235.60 Mn 80.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 116,089.00
Jun 30, 2025 164,692.00
Mar 31, 2025 135,308.00
Dec 31, 2024 130,729.00
Sep 30, 2024 107,692.00
Jun 30, 2024 161,529.00
Mar 31, 2024 138,471.00
Dec 31, 2023 137,591.00
Sep 30, 2023 100,702.00
Jun 30, 2023 168,879.00
Mar 31, 2023 131,121.00
Dec 31, 2022 117,643.00
Sep 30, 2022 100,000.00
Jun 30, 2022 172,474.00
Mar 31, 2022 127,526.00
Dec 31, 2021 122,368.00
Sep 30, 2021 100,000.00
Jun 30, 2021 169,174.00
Mar 31, 2021 130,826.00
Dec 31, 2020 129,814.00